About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug Offers Hope for Patients With Cystic Fibrosis

by VR Sreeraman on September 10, 2008 at 2:52 PM
 New Drug Offers Hope for Patients With Cystic Fibrosis

A new drug candidate has been found to hold promise for cystic fibrosis patients.

Dr David Sheppard from the University of Bristol said that the early results with VX-770 suggest that drug therapies, which target defects at the root of the disease, have the potential to greatly improve the quality of life of CF patients.

Advertisement

Currently, there is no cure for CF caused due to a defective gene that causes ducts and tubes in the body to become blocked by thick, sticky mucus. This mucus affects the lungs, pancreas, the intestines, the liver and the reproductive organs. One of the most recognisable symptoms of CF is 'salty sweat', caused by the failure of the sweat ducts to reabsorb salt

The defective gene disables or destroys a protein known as CFTR.

The research team led by Sheppard is investigating how new drugs restore function to defective CFTR proteins.
Advertisement

The new drug therapy (VX-770) was developed by Vertex Pharmaceuticals and will tackle the 'functional' defect.

The researchers have tested the drug on patients in the US who carry a genetic defect known as G551D.

The early results were encouraging. Patients who received 150mg twice a day saw the concentration of salt in their sweat decrease by almost 50 per cent and lung function improve by 10 per cent.

The study was presented at the BA Festival of Science in Liverpool.

Source: ANI
SRM
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

New Drug Offers Hope for Patients With Cystic Fibrosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests